Data from Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer
Chelsea Bolyard(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Balveen Kaur(Augusta University), Timothy P. Cripe(Nationwide Children's Hospital), Karuppaiyah Selvendiran(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Pin-Yi Wang(Nationwide Children's Hospital), Jianying Zhang(Shanxi Agricultural University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Uksha Saini(Ohio State University Hospital), Kellie S. Rath(Gynecologic Oncology Group)
Cited by 0
Related Papers
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360
Characterization of differential properties of rabbit tendon stem cells and tenocytes
|BMC Musculoskeletal Disorders|2010|345
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332